Marquié, Marta http://orcid.org/0000-0002-0660-0950
Valero, Sergi http://orcid.org/0000-0002-6599-948X
Martínez, Joan
Alarcón-Martín, Emilio
García-Sánchez, Ainhoa
de Rojas, Itziar
Castilla-Martí, Miguel
Castilla-Martí, Luis
Hernández, Isabel
Rosende-Roca, Maitée
Vargas, Liliana
Tartari, Juan Pablo
Esteban-De Antonio, Ester
Bojaryn, Urszula
Pytel, Vanesa
Narvaiza, Leire
Alegret, Montserrat
Ortega, Gemma
Espinosa, Ana
Sanabria, Ángela
Pérez-Cordón, Alba
Lleonart, Núria
Muñoz, Nathalia
Tárraga, Lluís
Ruiz, Agustín http://orcid.org/0000-0003-2633-2495
Boada, Mercè http://orcid.org/0000-0003-2617-3009
Article History
Received: 2 March 2022
Accepted: 28 September 2022
First Online: 8 October 2022
Competing interests
: MB has consulted for Araclon, Avid, Grifols, Lilly, Nutricia, Roche, Eisai and Servier. She received fees from lectures and funds for research from Araclon, Biogen, Grifols, Nutricia, Roche and Servier. She reports grants/research funding from Abbvie, Araclon, Biogen Research Limited, Bioiberica, Grifols, Lilly, S.A, Merck Sharp & Dohme, Kyowa Hakko Kirin, Laboratorios Servier, Nutricia SRL, Oryzon Genomics, Piramal Imaging Limited, Roche Pharma SA, and Schwabe Farma Iberica SLU, all outside the submitted work. She has not received personal compensations from these organizations. The rest of authors declare that they have no competing interests.